2 Growth Stocks That Could Rocket Higher Before the End of 2023
Growth-oriented investors looking for stocks that can heat up their portfolios before the end of 2023 want to turn their attention to the healthcare sector. Upcoming binary events could soon send these two biotech stocks rocketing higher.
The U.S. Food and Drug Administration (FDA) is scheduled to make some important approval decisions before the end of the year. A positive result could send shares of the drugmakers involved soaring, but there are no guarantees. Here's what you should know about these volatile stocks and their upcoming catalysts.
Alnylam (NASDAQ: ALNY) develops drugs made from small strands of RNA that interfere with the production of troublesome proteins. The company's first treatment, Onpattro, halts the production of a protein called transthyretin before it can unravel and form amyloid plaques that damage peripheral nerves, the heart, and other organs.
Source Fool.com
